{"meshTagsMajor":["Immunotherapy"],"meshTags":["Triple Negative Breast Neoplasms","Precision Medicine","Humans","Antigens, Neoplasm","Female","RNA, Messenger","Mutation","Immunotherapy","Cancer Vaccines","Genome","Biomarkers, Tumor"],"meshMinor":["Triple Negative Breast Neoplasms","Precision Medicine","Humans","Antigens, Neoplasm","Female","RNA, Messenger","Mutation","Cancer Vaccines","Genome","Biomarkers, Tumor"],"publicationTypes":["Clinical Trial, Phase I","Clinical Trial, Phase II","Journal Article","Multicenter Study"],"title":"Mutanome Engineered RNA Immunotherapy (MERIT).","pubmedId":"26086755"}